QQ客服 官方微博 反馈留言

	Bortezomib-based treatment can improve factor X activity in immunoglobulin light-chain amyloidosis with factor X deficiency
	Wu Xia; Miao Hui-Lei; Zhu Tie-Nan; Feng Jun; Zhang Lu; Mao Yue-Ying; Zhou Dao-Bin; Cao Xin-Xin; Li Jian
	2019
页码	1-2
ISSN号	1744-2818
DOI	10.1080/13506129.2019.1663815
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6335542
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wu Xia,Miao Hui-Lei,Zhu Tie-Nan,et al. Bortezomib-based treatment can improve factor X activity in immunoglobulin light-chain amyloidosis with factor X deficiency[J],2019:1-2.
APA	Wu Xia.,Miao Hui-Lei.,Zhu Tie-Nan.,Feng Jun.,Zhang Lu.,...&Li Jian.(2019).Bortezomib-based treatment can improve factor X activity in immunoglobulin light-chain amyloidosis with factor X deficiency.,1-2.
MLA	Wu Xia,et al."Bortezomib-based treatment can improve factor X activity in immunoglobulin light-chain amyloidosis with factor X deficiency".(2019):1-2.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。